Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel in STEMI undergoing primary PCI
IRCT20210718051935N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in myocardial infarction (MI) comparing Ticagrelor with Clopidogrel (2 arms). Primary endpoints: Thrombosis, Duration of hospitalization and 2 more. Started Aug 2021; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20210718051935N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210718051935N1.